Healthcare Strategy & Consulting

At Medicys, we partner with leading global strategy and consulting firms who advise healthcare business leaders on their most critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers & acquisitions. Typical projects in this space will focus on:

Market Sizing & Value Proposition development
Digital Marketing & Sales Strategy
End-to-End Patient Experience Strategy
Asset identification and acquisition
Telehealth implementation
Portfolio management and prioritisation
Patient Support Program (PSP) strategy
Strategic positioning
Competitive analysis

In practice, we do this through providing primary research services to provide the market understanding and evidence needed to support the analysis and strategic recommendations of the consulting team.

We can connect healthcare consultants with the respondents they need, be they health care professionals, KOLs and/or local, regional or national level payers, patients, patient organisations or other relevant targets to inform their strategy planning.

The properly sourced and well vetted research participants we can access are key to produce actionable insight.

Related Work

See all Work

healthcare strategy and consulting

Therapy Area: Neurology

Topic: AD

Respondent Type: Neurologists

Understand the opportunity for product X and assess the impact of potential asset differentiators: route of administration, patient identification & testing, patient reported outcomes

Countries:

Sample Size: 22

Methodology: 60 minute Web Assisted Telephone Depth Interviews (WATDIs)

Services Delivered: Translations, recruitment, moderation and transcripts

healthcare strategy and consulting

Therapy Area: Haematology

Topic: MM

Respondent Type: Haematologists

To understand current treatment decisions and practices in Multiple Myeloma, familiarity with the future entrants into the market (including discussing and reviewing hypothetical future product profiles) and how they may be positioned for optimal treatment of Multiple Myeloma in the future.

Countries:

Sample Size: 16

Methodology: 60 minute Web Assisted Telephone Depth Interviews (WATDIs). N=2 x vCL days.

Services Delivered: Recruitment, content analysis

healthcare strategy and consulting

Therapy Area: Haematology

Topic: CAR-T

Respondent Type: CAR-T haematologists

To better understand the current and future CAR-T therapy landscape in Multiple Myeloma and how decisions around these therapies will be made

Countries:

Sample Size: 65

Methodology: 60 minute Web Assisted Telephone Depth Interviews (WATDIs)

Services Delivered: Translations, recruitment, moderation, sim trans, transcripts

healthcare strategy and consulting

Therapy Area: Psychiatry

Topic: TRD

Respondent Type: Local and regional payers and Payer Advising Key Opinion Leaders (PA-KOLs)

To understand formulary access process, views on Product X and evidence payers want; specific focus on a therapeutic model (value statements and their importance in convincing payers to include the therapy in a formulary/decide to reimburse it)

Countries: